Close Menu

Lifecode

The deal, which comes about three months after Lifecode's acquisition by MedGenome, marks Vela's first foray into the genomic data interpretation market.

The acquisition will give India's MedGenome access to a CLIA-certified and CAP-accredited laboratory in the Bay Area so that it can expand its operations in the US.

The previously undisclosed Series A Round financing was led by Sequoia Capital, Mayo Clinic, and Mayo Ventures. 

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.